转移因子联合死卡介苗对肿瘤术后患者T细胞亚群的影响  

Effect of TF Combined with Extinct BCG on T Lymphocyte subpopulation in peripheral Blood of Tumor-Removing Patients

作　　者：贾明[1] 邹红云[1] 李力[1] 李增齐[1] 

机构地区：[1]兰州军区乌鲁木齐总医院临床医学研究所,830000

出　　处：《黑龙江医药科学》2000年第6期7-8,共2页Heilongjiang Medicine and Pharmacy

摘　　要：采用APAA法，检测了52例肿瘤术后患者治疗前后外周血T细胞亚群，以观察转移因子联合死卡介苗的免疫调节作用。结果表明，肿瘤术后患者T细胞亚群分布异常，在应用转移因子联合死卡介苗治疗后，CD、CD和CD/CD明显高于治疗前，与单纯转移因子组或死卡介苗组相比差异具有显著性(P<0.05)。转移因子联合死卡介苗对于提高肿瘤术后患者的细胞免疫功能不失为一种经济实用的治疗方法。Objective: To evaluate the effect of TF(transfer factor) combined with extinct BCG on immunity. Method: The percentages of CD and CD in T cells and the ratio of CD/CD in peripheral blood of 52 patients whose tumors had been removed were tested by APAA. Results: The distribution of T lymphocyte subpopulation was unnormal in peripheral blood of these patients. The percentages and the ratio were higher after treatment than those before treatment, with a significant difference in the percentages and the ratio between group C (treated with TF combined with extinct BCG) and group A or B (treated only with TF or BCG). The result suggests that treatment with TF combined with extinct BCG is a helpful method to improve cell immunity.

关 键 词：肿瘤 T细胞亚群 转移因子 死卡介苗 

分 类 号：R730.5[医药卫生—肿瘤]